Under construction – not a live service
Sign in
Taking people in United StatesPhase 4

Vitamin D Homeostasis in Sarcoidosis

Key facts

Where
Dallas, United StatesSee the site
Phase
Phase 4

Where in United States

  • University of Texas Southwestern Medical Center, and Parkland Health and Hospital SystemDallas, United StatesContact: Connie Hsia, MD (principal investigator)Taking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
University of Texas Southwestern Medical Center
Trial code
NCT03621553
Record updated
3 September 2026
Original description
This study evaluates the relationship between vitamin-D status and severity of sarcoidosis, and the effects of vitamin-D repletion in vitamin-D insufficient patients with sarcoidosis. Half the patients with sarcoidosis who are vitamin-D insufficient will receive standard vitamin-D supplementation via standard regimen while the other half will receive a placebo. Sarcoidosis patients who are vitamin-D sufficient will also act as controls.Read full original descriptionShow less

This study evaluates the relationship between vitamin-D status and severity of sarcoidosis, and the effects of vitamin-D repletion in vitamin-D insufficient patients with sarcoidosis. Half the patients with sarcoidosis who are vitamin-D insufficient will receive standard vitamin-D supplementation via standard regimen while the other half will receive a placebo. Sarcoidosis patients who are vitamin-D sufficient will also act as controls.

Inclusion: Stable medical condition defined as no hospitalization or emergency room visit in the previous 3 months; No evidence of active pulmonary or systemic infection; No other active inflammatory disease,; No active malignancy; Normal serum ionized calcium level.

Exclusion: Hospitalization or emergency room visit in the previous 3 months; Evidence of active pulmonary or systemic infection; Evidence of active other inflammatory disease; Evidence of active malignancy; Elevated serum ionized calcium level.

ClinicalTrials.gov NCT03621553